ESC 365 - Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment.

ESC Premium Access

Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment.

Session: Poster session 2 - Digging deeper into oral anticoagulants

Topic: Drug therapy

Speaker: Doctor T. Moumneh (Angers, FR)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Thomas Moumneh

University Hospital of Angers, Angers (France)

0 follower

4 more presentations in this session

Clinical effectiveness of new oral anticoagulants in US and Europe for stroke prevention in atrial fibrillation

Speaker: Mr M. Tarsillo (North Haven, US)

Effects of factor Xa inhibitors rivaroxaban and apixaban on platelet function

Speaker: Associate Professor G. Renda (Chieti, IT)

Impact of hemorrhagic events during dual antiplatelet therapy after drug-eluting stent implantation in patients with hemodialysis

Speaker: Doctor A. Shimizu (Kitakyushu, JP)

Use of vitamin K antagonists in patients aged 85 years or over: analysis of thromboembolic and hemorrhagic events.

Speaker: Doctor D. Moreira (Sao Paulo, BR)

Access the full session

Poster session 2 - Digging deeper into oral anticoagulants

Speakers: Doctor T. Moumneh, Mr M. Tarsillo, Associate Professor G. Renda, Doctor A. Shimizu, Doctor D. Moreira

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources